Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Promis Neurosciences (PMN) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-10.12M |
|
-- |
|
-- |
|
$10.18M |
|
$-10.18M |
|
$0.07M |
|
$-10.12M |
|
$-10.12M |
|
$-10.12M |
|
$-10.12M |
|
$-10.12M |
|
$-10.12M |
|
$-10.18M |
|
$-10.18M |
|
34.85M |
|
34.85M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$9.51M |
|
-- |
|
-- |
|
$9.51M |
|
$9.82M |
|
-- |
|
$0.07M |
|
$9.89M |
|
$-0.38M |
|
$-0.38M |
|
$-0.38M |
|
32.69M |
|
| Cash Flow Statement Financials | |
$-8.78M |
|
-- |
|
-- |
|
$13.29M |
|
$4.51M |
|
$-8.78M |
|
$0.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.97 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
2644.41% |
|
2644.44% |
|
-106.39% |
|
2644.44% |
|
$-0.01 |
|
$-0.25 |
|
$-0.25 |
|